There were no significant differences between groups in either body weight (P = 0.98) or age (P = 0.10).
There were no significant differences between groups in triglycerides, body mass index, or systolic or diastolic blood pressure at baseline or during follow-up.
We observed no significant difference between exposure groups in body weight, fasting blood glucose level, glucose tolerance (IPGTT), or insulin sensitivity (ITT) at baseline (prior to consumption of the HFD or assignment to exposure groups).
There were no significant differences between the groups in body weight, age, and gender (Table 1).> The disturbances of venous cerebral blood flow determined by an transcranial Doppler, deferred stroke, head injury, encephalopathy, hypertension were more frequently observed in the E group.
A multidisciplinary solution focused obesity intervention performed in groups of families and in single families showed no between-group effect in body mass index after 12 months.
There was no significant difference between the two groups in body weight between the first and subsequent treatments.
No significant differences were found between groups in weight or body composition.
There were no significant differences within groups or between groups in BMI, % body fat, waist circumference, or blood pressure at 12 weeks.
38 A similar proportion of patients in each group also experienced alanine aminotransferase/aspartate aminotransferase changes, and there were no statistically significant differences between groups in vital signs, body weight or QT interval.
Although no differences were observed between groups in percentage of body fat, fat mass, and fat-free mass, effect sizes for the time by group interaction for these variables suggested a large effect of the interventions (effect sizes: 0.369, 0.267, and 0.342, respectively).
